|
Volumn 194, Issue 1, 2016, Pages 118-120
|
Effect of Anti-IL-13 treatment on airway dimensions in severe asthma
a b c d c d d e |
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
TRALOKINUMAB;
INTERLEUKIN 13;
MONOCLONAL ANTIBODY;
ADULT;
ASTHMA;
CLINICAL ARTICLE;
COMPUTED TOMOGRAPHY SCANNER;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
HUMAN;
IMAGING SOFTWARE;
LETTER;
MALE;
MIDDLE AGED;
PHASE 2 CLINICAL TRIAL (TOPIC);
POST HOC ANALYSIS;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SPIRAL COMPUTER ASSISTED TOMOGRAPHY;
TREATMENT OUTCOME;
AIRWAY REMODELING;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
DRUG EFFECTS;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
AIRWAY REMODELING;
ANTIBODIES, MONOCLONAL;
ASTHMA;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INTERLEUKIN-13;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
EID: 84988884704
PISSN: 1073449X
EISSN: 15354970
Source Type: Journal
DOI: 10.1164/rccm.201511-2224LE Document Type: Letter |
Times cited : (14)
|
References (5)
|